Over the last few years, we have seen 3D models becoming more popular and sophisticated – drug developers are keen on adopting and utilizing these new platforms to enhance their confidence in both drug discovery and preclinical development phases.
There are still several challenges that need to be solved: from reproducibility to costs of models to quality control. Our senior community members including the likes of VP of Preclinical, Translational Studies and PKPD are eager to partner with 3D model developers, CROs, imaging specialists who can help them advance their drug development programs, bringing the next generation therapeutics to patients as quickly and safely as possible.
If you have a unique platform or service that can add value to accelerate 3D model advancements, we would love to hear from you!
- Showcase your pioneering technology and be the 3D model influencer amongst our senior leaders by demonstrating expertise through an expert content piece
- Discover what pharma and biotech need from you, and align your services for their business needs
- Network with world-class industry leaders who are committed to making a change in 3D model adoption
Drop me a line and we can discuss how our summit and series can help you achieve your brand profile and commercial objectives.